North Shore Hematology/Oncology Associates — East Setauket, New York

North Shore Hematology/Oncology Associates is a clinical research site located in East Setauket, New York, United States 11733.

Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

North Shore Hematology/Oncology Associates has participated in 4 clinical trials.

Therapeutic areas: Diffuse Large B-cell Lymphoma, de Novo DLBCL, DLBCL Transformed From Indolent Lymphoma.

Sponsors: CTI BioPharma, Gilead Sciences, Eisai Inc..

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for North Shore Hematology/Oncology Associates?

North Shore Hematology/Oncology Associates has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has North Shore Hematology/Oncology Associates conducted?

North Shore Hematology/Oncology Associates has 4 clinical trials on record. Their work covers Diffuse Large B-cell Lymphoma, de Novo DLBCL, DLBCL Transformed From Indolent Lymphoma.

Is North Shore Hematology/Oncology Associates accredited by Crixeo Health?

North Shore Hematology/Oncology Associates has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about North Shore Hematology/Oncology Associates?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.